Herbal Drug Discovery: Challenges and Perspectives

Q4 Pharmacology, Toxicology and Pharmaceutics
S. Parasuraman
{"title":"Herbal Drug Discovery: Challenges and Perspectives","authors":"S. Parasuraman","doi":"10.2174/1875692116666180419153313","DOIUrl":null,"url":null,"abstract":"DOI: 10.2174/1875692116666180419153313 Abstract: Plants are very useful to mankind, and many plants are exclusively used by humans for medical purposes to prevent or treat diseases. In recent decades, natural products including medicinal plants have gained major attention in the pharmaceutical research field. Medicinal plants are the richest and commonly available sources for drug discovery. Many pharmaceutical lead molecules are derived from plants. The cost of the treatment, duration of illness and adverse effect/ toxicity of allopathic drugs cause an increase in the use of alternative systems of medicines, which lead to the drastic development of herbal drugs industry. The estimated market for pharma and pharma products in 2022 is $1.12 trillion and this indicates the global pharma needs. This may be due to changes in lifestyle and increased risk of infection globally. The World Health Organization recommends the practice of the traditional system of medicine as it is affordable, safe and culturally acceptable. The objective of this review article is to summarize the importance of plants in drug discovery, current perspectives and challenges.","PeriodicalId":11056,"journal":{"name":"Current Pharmacogenomics and Personalized Medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"29","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Pharmacogenomics and Personalized Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1875692116666180419153313","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 29

Abstract

DOI: 10.2174/1875692116666180419153313 Abstract: Plants are very useful to mankind, and many plants are exclusively used by humans for medical purposes to prevent or treat diseases. In recent decades, natural products including medicinal plants have gained major attention in the pharmaceutical research field. Medicinal plants are the richest and commonly available sources for drug discovery. Many pharmaceutical lead molecules are derived from plants. The cost of the treatment, duration of illness and adverse effect/ toxicity of allopathic drugs cause an increase in the use of alternative systems of medicines, which lead to the drastic development of herbal drugs industry. The estimated market for pharma and pharma products in 2022 is $1.12 trillion and this indicates the global pharma needs. This may be due to changes in lifestyle and increased risk of infection globally. The World Health Organization recommends the practice of the traditional system of medicine as it is affordable, safe and culturally acceptable. The objective of this review article is to summarize the importance of plants in drug discovery, current perspectives and challenges.
草药药物发现:挑战与展望
摘要:植物对人类非常有用,许多植物被人类专门用于医学目的,以预防或治疗疾病。近几十年来,包括药用植物在内的天然产物在药物研究领域受到了广泛关注。药用植物是最丰富和最常见的药物发现来源。许多药用铅分子是从植物中提取的。治疗费用、疾病持续时间和对抗药物的不良反应/毒性导致替代药物系统的使用增加,从而导致草药工业的急剧发展。预计到2022年,医药和医药产品的市场规模将达到1.12万亿美元,这表明了全球医药需求。这可能是由于生活方式的改变和全球感染风险的增加。世界卫生组织建议采用传统医学体系,因为它负担得起、安全且在文化上可接受。本文综述了植物在药物开发中的重要性、研究现状和面临的挑战。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Pharmacogenomics and Personalized Medicine
Current Pharmacogenomics and Personalized Medicine Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
0.40
自引率
0.00%
发文量
11
期刊介绍: Current Pharmacogenomics and Personalized Medicine (Formerly ‘Current Pharmacogenomics’) Current Pharmacogenomics and Personalized Medicine (CPPM) is an international peer reviewed biomedical journal that publishes expert reviews, and state of the art analyses on all aspects of pharmacogenomics and personalized medicine under a single cover. The CPPM addresses the complex transdisciplinary challenges and promises emerging from the fusion of knowledge domains in therapeutics and diagnostics (i.e., theragnostics). The journal bears in mind the increasingly globalized nature of health research and services.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信